Gene Patent in Cancer Test Upheld by Federal Appeals PanelNYTimes.com: The court ruled that DNA isolated from the body was eligible for patents because it was “markedly different” in its chemical structure from DNA that exists in the body. As a result, the isolated DNA is not simply a product of nature, which would not be eligible for a patent. Association for Molecular Pathology v. U.S. Patent and Trademark Office, No. 2010-1406 (Fed. Cir., July 29, 2011) |